Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL15612335 | 1.00 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL17941716 | 0.96 | SLC34A1 (0.61) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL40491 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL101070 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL28894407 | 0.95 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL6155231 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL4731817 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL8972786 | 0.95 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL14656197 | 0.95 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL653726 | 0.95 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4098267-A1 | MEDICINAL COMPOSITION COMPRISING DENTAL PULP-DERIVED CELLS | JCR Pharmaceuticals Co., Ltd. (JP) | 2022-12-07 | — | — | EP | disclosed |
| EP-3219322-A1 | MUSCULAR DYSTROPHY THERAPEUTIC AGENT CONTAINING PLURIPOTENT STEM CELLS DERIVED FROM DENTAL PULP | JCR Pharmaceuticals CO., LTD. (JP) | 2017-09-20 | — | — | EP | disclosed |
| EP-2832850-B1 | METHOD FOR PRODUCING PLURIPOTENT STEM CELLS DERIVED FROM DENTAL PULP | JAPAN CHEM RES (JP) | 2017-09-06 | — | — | EP | disclosed |
| CN-101264338-B | Calcium phosphate cement | HOWMEDICA LEIBINGER INC | 2012-05-09 | — | — | CN | disclosed |
| EP-1712245-B1 | Calcium phosphate cement | HOWMEDICA OSTEONICS CORP (US) | 2012-02-01 | — | — | EP | disclosed |
| EP-2260877-A1 | Calcium phosphate cement | STRYKER CORPORATION (US) | 2010-12-15 | — | — | EP | disclosed |
| CN-100460021-C | Calcium phosphate cement | HOWMEDICAL LEIBINGER INC D B A (US) | 2009-02-11 | — | — | CN | disclosed |
| CN-101264338-A | Calcium phosphate cement | HOWMEDICA LEIBINGER INC (US) | 2008-09-17 | — | — | CN | disclosed |
| EP-1938844-A2 | Calcium phosphate cement | Howmedica Leibinger Inc. (US) | 2008-07-02 | — | — | EP | disclosed |
| EP-1712245-A2 | Calcium phosphate cement | Howmedica Leibinger Inc. (US) | 2006-10-18 | — | — | EP | disclosed |
| US-20060225621-A1 | Injectable calcium phosphate cement | HOWMEDICA LEIBINGER INC. (US) | 2006-10-12 | — | — | US | disclosed |
| CN-1844010-A | Calcium phosphate cement | HOWMEDICAL LEIBINGER INC D B A (US) | 2006-10-11 | — | — | CN | disclosed |